» Articles » PMID: 35720333

Non-Coding RNAs As Novel Regulators of Neuroinflammation in Alzheimer's Disease

Overview
Journal Front Immunol
Date 2022 Jun 20
PMID 35720333
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is one of the most common causes of dementia. Although significant breakthroughs have been made in understanding the progression and pathogenesis of AD, it remains a worldwide problem and a significant public health burden. Thus, more efficient diagnostic and therapeutic strategies are urgently required. The latest research studies have revealed that neuroinflammation is crucial in the pathogenesis of AD. Non-coding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), PIWI-interacting RNAs (piRNAs), and transfer RNA-derived small RNAs (tsRNAs), have been strongly associated with AD-induced neuroinflammation. Furthermore, several ongoing pre-clinical studies are currently investigating ncRNA as disease biomarkers and therapeutic interventions to provide new perspectives for AD diagnosis and treatment. In this review, the role of different types of ncRNAs in neuroinflammation during AD are summarized in order to improve our understanding of AD etiology and aid in the translation of basic research into clinical practice.

Citing Articles

Long Non-Coding RNAs: Crucial Regulators in Alzheimer's Disease Pathogenesis and Prospects for Precision Medicine.

Yang C, Li Y, Chen C, Sun Z, Liu E, Wei N Mol Neurobiol. 2025; .

PMID: 39907902 DOI: 10.1007/s12035-025-04729-4.


Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics.

Chunhui G, Yanqiu Y, Jibing C, Ning L, Fujun L Metab Brain Dis. 2025; 40(1):84.

PMID: 39754674 PMC: 11700052. DOI: 10.1007/s11011-024-01520-7.


Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis.

S S, L S D, Rajendran P, N H, S A IBRO Neurosci Rep. 2024; 17:441-455.

PMID: 39629018 PMC: 11612366. DOI: 10.1016/j.ibneur.2024.11.004.


The Association and Prognostic Implications of Long Non-Coding RNAs in Major Psychiatric Disorders, Alzheimer's Diseases and Parkinson's Diseases: A Systematic Review.

Zhu L, Guo M, Li K, Guo C, He K Int J Mol Sci. 2024; 25(20).

PMID: 39456775 PMC: 11507000. DOI: 10.3390/ijms252010995.


Unveiling the Network regulatory mechanism of ncRNAs on the Ferroptosis Pathway: Implications for Preeclampsia.

Zhang Y, Zhang J, Chen S, Li M, Yang J, Tan J Int J Womens Health. 2024; 16:1633-1651.

PMID: 39372667 PMC: 11451465. DOI: 10.2147/IJWH.S485653.


References
1.
Wang X, Liu D, Huang H, Wang Z, Hou T, Yang X . A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease. Biol Psychiatry. 2017; 83(5):395-405. DOI: 10.1016/j.biopsych.2017.07.023. View

2.
Xu N, Li A, Ji L, Ye Y, Wang Z, Tong L . miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q. Eur J Histochem. 2019; 63(2). PMC: 6511887. DOI: 10.4081/ejh.2019.3008. View

3.
Roush S, Slack F . The let-7 family of microRNAs. Trends Cell Biol. 2008; 18(10):505-16. DOI: 10.1016/j.tcb.2008.07.007. View

4.
Hammond S, Aartsma-Rus A, Alves S, Borgos S, Buijsen R, Collin R . Delivery of oligonucleotide-based therapeutics: challenges and opportunities. EMBO Mol Med. 2021; 13(4):e13243. PMC: 8033518. DOI: 10.15252/emmm.202013243. View

5.
Xu X, Zhang J, Tian Y, Gao Y, Dong X, Chen W . CircRNA inhibits DNA damage repair by interacting with host gene. Mol Cancer. 2020; 19(1):128. PMC: 7446195. DOI: 10.1186/s12943-020-01246-x. View